Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using a shoulder sling to improve balance and mobility in stroke recovery

Official title: A Cross-Over Study on the Effect of Shoulder Sling Use on Balance and Functional Mobility in Patients With Hemiplegia During the Subacute Phase of Stroke Rehabilitation

Run by University of West Attica · NCT06904768 · Data updated 2026-11-12

This study is testing if using a shoulder sling can help people recovering from a stroke improve their balance and mobility.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment17 (estimated)
SponsorUniversity of West Attica
Academic / other
Locations1 site (Koropí, Attica)
StatusRecruiting
StartedMarch 13, 2025
Main results expectedApril 2025
Study endsApril 2025
Registry record updatedApril 1, 2025
Trial IDNCT06904768 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 40 to 80 who have experienced a stroke in the subacute phase and have hemiplegia affecting one upper limb.

Probably not a fit

Patients with severe cognitive impairment, significant orthopedic conditions, or those unable to use the sling due to other medical issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of a shoulder sling in enhancing balance and mobility for individuals recovering from a stroke in the subacute phase. Participants will undergo a series of validated functional tests, including the Timed Up and Go test, the Functional Reach Test, and the Modified Four Square Step Test, both with and without the sling in a randomized order. The goal is to assess whether the sling provides measurable benefits in stability and performance during movement tasks. Data collection will occur in rehabilitation centers under the supervision of clinical researchers.

Why it matters

Potential benefit: If successful, this intervention could significantly improve the stability and mobility of stroke patients, enhancing their ability to perform daily activities safely.

How similar studies have gone: While the specific use of a shoulder sling in this context may be novel, similar studies have shown that targeted interventions can improve mobility and balance in stroke recovery.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Clinical diagnosis of stroke in the subacute phase (up to 6 months post-onset)
* Hemiplegia affecting one upper limb
* Brunnstrom stage \< 4 for the affected upper limb
* Functional Ambulation Category (FAC) score \> 3
* Age between 40 and 80 years
* Ability to follow simple instructions
* Medically stable to participate in balance and mobility testing
* Signed informed consent

Exclusion Criteria:

* Severe cognitive impairment (e.g. MMSE \< 23)
* Visual or vestibular disorders affecting balance
* Significant orthopedic or musculoskeletal conditions of the lower limbs
* Uncontrolled cardiovascular or pulmonary disease
* Use of assistive devices that prevent sling application
* Severe aphasia interfering with understanding or communication
* Skin lesions or injuries at the shoulder region preventing sling use

Where it's running

  • Filoktitis Recovery and Rehabilitation Center
    Koropí, Attica, Greece
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.